Review of antiretroviral therapy coverage in 10 highest burden HIV countries in Africa: 2015–2020
暂无分享,去创建一个
A. Babatunde | H. Isah | Oluwawapelumi D Akin-Ajani | T. O. Togunwa | R. O. Abdullateef | Oluwawapelumi Akin-Ajani | R. Abdullateef
[1] S. Odafe,et al. Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge , 2021, PloS one.
[2] R. King,et al. Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study , 2021, JMIR mHealth and uHealth.
[3] G. Kayode,et al. Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study , 2021, PloS one.
[4] M. Fox,et al. Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis , 2021, PLoS ONE.
[5] I. Jani,et al. Inpatient Point-of-Care HIV Early Infant Diagnosis in Mozambique to Improve Case Identification and Linkage to Antiretroviral Therapy , 2021, Global Health: Science and Practice.
[6] R. Hayes,et al. A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV+ patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study , 2021, Trials.
[7] S. Pals,et al. High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chókwè Health Demographic Surveillance System, Mozambique, 2014-2019. , 2020, Journal of acquired immune deficiency syndromes.
[8] J. Baeten,et al. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial , 2020, The Lancet. Global health.
[9] N. Jewell,et al. Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial. , 2020, The lancet. HIV.
[10] A. Misganaw,et al. Progress towards the 2020 fast track HIV/AIDS reduction targets across ages in Ethiopia as compared to neighboring countries using global burden of diseases 2017 data , 2020, BMC Public Health.
[11] M. Fox,et al. Differentiated HIV care in South Africa: the effect of fast‐track treatment initiation counselling on ART initiation and viral suppression as partial results of an impact evaluation on the impact of a package of services to improve HIV treatment adherence , 2019, Journal of the International AIDS Society.
[12] A. L. Nyondo-Mipando,et al. Factors influencing adherence to antiretroviral treatment among adults accessing care from private health facilities in Malawi , 2019, BMC Public Health.
[13] L. Berrie,et al. Monitoring viral load for the last mile: what will it cost? , 2019, Journal of the International AIDS Society.
[14] R. Zulliger,et al. Mozambique’s Community Antiretroviral Therapy Support Group Program: The Role of Social Relationships in Facilitating HIV/AIDS Treatment Retention , 2019, AIDS and Behavior.
[15] E. Szumilin,et al. Point‐of‐care viral load monitoring: outcomes from a decentralized HIV programme in Malawi , 2019, Journal of the International AIDS Society.
[16] M. Fox,et al. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa , 2019, PLoS medicine.
[17] B. Sartorius,et al. Towards UNAIDS Fast-Track goals: targeting priority geographic areas for HIV prevention and care in Zimbabwe , 2019, AIDS.
[18] Muddukrishna Badamane Sathyanarayana,et al. President’s Emergency Plan for AIDS Relief , 2018, Systematic Reviews in Pharmacy.
[19] S. McCoy,et al. The heterogeneous effect of short-term transfers for improving ART adherence among HIV-infected Tanzanian adults , 2018, AIDS care.
[20] E. Okechukwu,et al. Bridging the HIV treatment gap in Nigeria: examining community antiretroviral treatment models , 2018, Journal of the International AIDS Society.
[21] S. Arinze-Onyia,et al. Do peer support groups have an effect on medication adherence? A study among people living with HIV/AIDS in Enugu State, Nigeria , 2018 .
[22] N. Ford,et al. Identifying models of HIV care and treatment service delivery in Tanzania, Uganda, and Zambia using cluster analysis and Delphi survey , 2017, BMC Health Services Research.
[23] C. Boeke,et al. Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial , 2017, Journal of acquired immune deficiency syndromes.
[24] S. Bautista-Arredondo,et al. Pilot study of a multi-pronged intervention using social norms and priming to improve adherence to antiretroviral therapy and retention in care among adults living with HIV in Tanzania , 2017, PloS one.
[25] R. Noor,et al. The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania , 2017, BMC Health Services Research.
[26] N. Jewell,et al. Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania , 2017, AIDS.
[27] A. Crampin,et al. Identifying gaps in HIV service delivery across the diagnosis-to-treatment cascade: findings from health facility surveys in six sub-Saharan countries , 2017, Journal of the International AIDS Society.
[28] Kebba Jobarteh,et al. Community ART Support Groups in Mozambique: The Potential of Patients as Partners in Care , 2016, PloS one.
[29] John Ashmore,et al. Adherence clubs for long‐term provision of antiretroviral therapy: cost‐effectiveness and access analysis from Khayelitsha, South Africa , 2016, Tropical medicine & international health : TM & IH.
[30] F. Meinck,et al. Achieving equity in HIV-treatment outcomes: can social protection improve adolescent ART-adherence in South Africa? , 2016, AIDS care.
[31] D. Bangsberg,et al. The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda , 2016, AIDS.
[32] Adeyemi Abayomi Awofala,et al. HIV epidemiology in Nigeria , 2016, Saudi journal of biological sciences.
[33] K. Torpey,et al. The Value of Support Group Participation in Influencing Adherence to Antiretroviral Treatment among People Living with Human Immunodeficiency Virus (HIV) , 2015 .
[34] T. Hallett,et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study , 2014, The Lancet.
[35] Dorothy Bray,et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.
[36] P. Mbabazi,et al. MINISTRY OF HEALTH, UGANDA , 2019 .
[37] B. Walker,et al. Antiretroviral therapy in early HIV infection. , 2013, The New England journal of medicine.
[38] Anthony Appiah,et al. Encyclopedia of Africa , 2010 .